Multidrug resistant bacteria market to reach $18.77 billion by 2030 at 7.4% cagr, driven by increasing prevalence of infectious diseases.
Read More
Mass spectrometry imaging market to reach $4.43 billion by 2030 at 9.0% CAGR, driven by rising demand for personalized medicine.
Read More
Mucolipidosis ii market to reach $16.19 billion by 2030 at 3.5% CAGR, driven by rise in gene therapy, increased research and development activities, and growing number of clinical trials.
Read More
Mantle cell lymphoma therapeutics market to reach $3.81 billion by 2030 at 8.1% CAGR, driven by rise in prevalence of mantle cell lymphoma.
Read More
Mtor inhibitors market to reach $10.39 billion by 2030 at 6.2% CAGR, driven by rise in prevalence of kidney diseases.
Read More
The global male infertility market to reach $5.76 billion by 2030 at 6.0% CAGR, driven by increasing stress levels.
Read More
The global male hypogonadism market to reach $5.34 billion by 2030 at 6.4% CAGR, driven by increase in infertility rates.
Read More
The global Msi-h and dmmr market to reach $21.13 billion by 2030 at 22.7% CAGR, driven by rising prevalence of cancer.
Read More
Mrna therapeutics cdmo market to reach $8.26 billion by 2030 at 11.7% CAGR, driven by growing burden of chronic and infectious diseases.
Read More
Malaria treatment market to reach $2.18 billion by 2030 at 6.5% CAGR, driven by high incidence of malaria and increase in healthcare spending.
Read More